HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

PON1 activity and total oxidant status in patients with active pulmonary tuberculosis.

AbstractOBJECTIVES:
The aim of this study was to the investigate effect of tuberculosis infection on paraoxonase-1 (PON1) activity and oxidative status in patients with pulmonary tuberculosis (PTB).
DESIGN AND METHODS:
Twenty-five active PTB subjects and 33 healthy controls were included in the study. Serum PON1 activity, total oxidant status (TOS), lipid hydroperoxide (LOOH) and total free sulfydryl (-SH) groups were determined.
RESULTS:
Serum basal/salt-stimulated paraoxonase activities, arylesterase activity and total -SH group levels were significantly lower in patients with PTB than controls (p<0.05, p<0.05, p<0.001 and p<0.01 respectively), while TOS and LOOH levels were significantly higher (p<0.01 and p<0.05, respectively). In PTB patients, TOS, LOOH and total -SH group levels were significantly correlated with paraoxonase (r=-0.371, p<0.05; r=-0.286, p<0.05; r=0.625 p<0.01; respectively) and arylesterase (r=-0.437, p<0.01; r=-0.352, p<0.05; r=0.653, p<0.01; respectively).
CONCLUSIONS:
Patients with active PTB are exposed to potent oxidative stress and they have decreased PON1 activity. These predisposal factors may, in part, play a role in the pathogenesis of atherosclerosis in PTB.
AuthorsSahbettin Selek, Niyet Cosar, Abdurrahim Kocyigit, Ozcan Erel, Nurten Aksoy, Mehmet Gencer, Faruk Gunak, Mehmet Aslan
JournalClinical biochemistry (Clin Biochem) Vol. 41 Issue 3 Pg. 140-4 (Feb 2008) ISSN: 0009-9120 [Print] United States
PMID18154731 (Publication Type: Journal Article)
Chemical References
  • Lipid Peroxides
  • Oxidants
  • Sulfhydryl Compounds
  • Aryldialkylphosphatase
Topics
  • Adult
  • Aryldialkylphosphatase (blood)
  • Atherosclerosis (blood, etiology)
  • Female
  • Humans
  • Lipid Peroxides (blood)
  • Male
  • Middle Aged
  • Oxidants (blood)
  • Oxidation-Reduction
  • Oxidative Stress
  • Reference Values
  • Sulfhydryl Compounds (blood)
  • Tuberculosis, Pulmonary (blood, complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: